author-photo

Béatrice Turcq

University of Bordeaux

32

Papers

825

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY-APPROVED L-ASPARAGINASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS

2021 Molecular metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (6)
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.

2020 JCI insight
Show All
- Source
- Cite
- Save
Citations (11)
ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY APPROVED KIDROLASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Novel analytical methods to interpret large sequencing data from small sample sizes

2019 Human Genomics
Show All
- Source
- Cite
- Save
Citations (1)
Midostaurin resistance in FLT3-ITD acute myeloblastic leukemia: Fonctional genomic screening by Crispr-Cas9

2019
Show All
- Source
- Cite
- Save
Citations (0)
Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line

2019 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (2)
Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency

2018
Show All
- Source
- Cite
- Save
Citations (0)
Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells

2018
Show All
- Source
- Cite
- Save
Citations (0)
A new mechanism of resistance to ABL1 tyrosine kinase inhibitors in a BCR-ABL1-positive cell line

2017 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (5)